A Study of SI-B001, an EGFR/HER3 Bispecific Antibody, in Locally Advanced or Metastatic Epithelial Tumors

NCT04603287 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Locally Advanced or Metastatic Epithelial Tumor

Interventions

DRUG: SI-B001

Sponsor

Sichuan Baili Pharmaceutical Co., Ltd.

Collaborators

[object Object]